CIRCULATORY FAILURE NEONATAL

This adverse event was reported 59 times

These drugs are most commonly taken by patients reporting CIRCULATORY FAILURE NEONATAL:

# Drug Count
0 FUROSEMIDE 8
1 OCRELIZUMAB 8
2 CARIPRAZINE 6
3 IBUPROFEN LYSINE 6
4 LITHIUM 6
5 LITHIUM BROMATUM 6
6 QUETIAPINE 6
7 DOPAMINE HYDROCHLORIDE 4
8 LEVOTHYROXINE SODIUM 4
9 LEVOTHYROXINE SODIUM ANHYDROUS 4
See all common drugs associated with CIRCULATORY FAILURE NEONATAL

CIRCULATORY FAILURE NEONATAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FACTOR XIII CONCENTRATE (HUMAN) 1 0.0110
1 IBUPROFEN LYSINE 6 0.0105
2 BERACTANT 1 0.0027
3 MEXILETINE HYDROCHLORIDE 1 0.0024
4 CHORIONIC GONADOTROPIN 1 0.0018
5 SOYBEAN OIL 1 0.0015
6 ROPIVACAINE HYDROCHLORIDE 3 0.0012
7 DOPAMINE HYDROCHLORIDE 4 0.0011
8 SUFENTANIL CITRATE 1 0.0008
9 FLURBIPROFEN 1 0.0007
See all drugs enriched for association with CIRCULATORY FAILURE NEONATAL

CIRCULATORY FAILURE NEONATAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 Lipid Emulsion [EPC] 1 0.0004
2 Monobactam Antibacterial [EPC] 1 0.0004
3 Oxytocic [EPC] 1 0.0003
4 Echinocandin Antifungal [EPC] 1 0.0001
5 Prostaglandin E1 Analog [EPC] 2 0.0001
6 Parenteral Iron Replacement [EPC] 1 0.0001
7 Penem Antibacterial [EPC] 2 0.0001
8 General Anesthetic [EPC] 2 0.0000
9 Glycopeptide Antibacterial [EPC] 3 0.0000
See all drug classes enriched for association with CIRCULATORY FAILURE NEONATAL